An update on HLA association of Mi-2 autoantibodies: The association with a tryptophan at position 9 of the HLA-DRβ chain is strong but not absolute

Arthritis and Rheumatism

Volumn 42, Issue 7, 1999, Pages 1552-1553

  Mierau, Rudolf ^a   Dick, Thomas ^a   Genth, Ekkehard ^a   Bartz Bazzanella, Peter ^b   Keller, Elisabeth ^c   Albert, Ekkehard D ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Kreiskrankenhaus Würselen   (Germany)

^c Laboratory for Immunogenetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DR ANTIGEN; TRYPTOPHAN;

ANTIBODY PRODUCTION; ARTICLE; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HLA TYPING; HUMAN; PRIORITY JOURNAL;

EID: 0033496502     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199907)42:7<1552::AID-ANR33>3.0.CO;2-K     Document Type: Article

References (11)

1. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985;28:796-803.
2. Aubry F, Mattei MG, Galibert F. Identification of a human 17p-located cDNA encoding a protein of the Snf2-like helicase family. Eur J Biochem 1998;254:558-64.
3. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 1995;38:1389-99.
4. Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN. Molecular analysis of a major antigenic region of the 240-kd protein of Mi-2 autoantigen. J Clin Invest 1995;96:1730-7.
5. Seelig HP, Renz M, Targoff IN, Ge Q, Frank MB. Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen [letter]. Arthritis Rheum 1996;39:1769-71.
6. Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E. Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DRβ chain. Arthritis Rheum 1996;39:868-76.
7. Nevinny-Stickel C, Hinzpeter M, Andreas A, Albert ED. Nonradioactive oligotyping for HLA-DR1-DR10 using polymerase chain reaction, digoxigenin-labeled oligonucleotides and chemiluminescent detection. Eur J Immunogenet 1991;18:323-32.
8. Keller E, Zhu Y, Volgger A, Lang B, Albert ED. A novel variant of DR4 (DRB1*0421) identified in a patient with polychondritis. Immunogenetics 1995;41:171.
9. Scharf SJ, Long CM, Erlich HA. Sequence analysis of the HLA-DR and HLA-DQ loci from three pemphigus vulgaris patients. Hum Immunol 1988;22:61-9.
10. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
11. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas MC, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.